Medicine & Life Sciences

1. Ovarian Neoplasms 100%
2. Melanoma 83%
3. Ovarian Epithelial Carcinoma 57%
4. T-Lymphocytes 46%
5. Neoplasms 40%
6. Survival 38%
7. Vaccines 28%
8. Neoadjuvant Therapy 27%
9. Immunotherapy 26%
10. Recurrence 25%
11. Folate Receptor 1 24%
12. Endometrial Neoplasms 23%
13. Subunit Vaccines 19%
14. Drug Therapy 19%
15. Immunity 18%
16. Dendritic Cells 17%
17. Therapeutics 17%
18. Nivolumab 16%
19. Vaccination 16%
20. protein kinase C lambda 16%
21. Methylation 15%
22. Biomarkers 15%
23. Auranofin 14%
24. SARS Virus 13%
25. Confidence Intervals 13%
26. Antigens 13%
27. Single Nucleotide Polymorphism 13%
28. Epigenomics 12%
29. Oncolytic Viruses 12%
30. Letrozole 12%
31. Peptides 12%
32. Humoral Immunity 12%
33. Safety 12%
34. Progression-Free Survival 12%
35. Uveal melanoma 12%
36. Tumor-Infiltrating Lymphocytes 11%
37. Cellular Immunity 11%
38. Neoplasm Metastasis 10%
39. glucopyranosyl lipid-A 10%
40. Genes 9%
41. Histology 9%
42. Ipilimumab 9%
43. Carcinoma 9%
44. Genome 9%
45. Antibodies 9%
46. Breast Neoplasms 9%
47. Tyrosine Phenol-Lyase 9%
48. Interleukin-2 8%
49. Paclitaxel 8%
50. Estrogen Receptors 8%